PN-101

· Paean Biotechnology Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PN-101, covering 2024-04-03 to 2025-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis [Phase 2]

See pricing